{"id":13536,"date":"2020-01-22T16:57:08","date_gmt":"2020-01-22T15:57:08","guid":{"rendered":"http:\/\/www.thema-med.com\/?p=13536"},"modified":"2023-01-25T16:45:09","modified_gmt":"2023-01-25T15:45:09","slug":"europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved","status":"publish","type":"post","link":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/","title":{"rendered":"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved"},"content":{"rendered":"\r\n

In December 2019 the European Medical Device Coordination Group (MDCG) released the Guidance notes for manufacturers of class I medical devices<\/a> and the Guidance on Cybersecurity for medical devices<\/a>.<\/p>\r\n\r\n\r\n\r\n

\"\"\r\n
The MDCG Guidance for Class I and cybersecurity has been approved<\/figcaption>\r\n<\/figure>\r\n\r\n\r\n\r\n

In particular, \u201cMDCG 2019-15 Guidance Notes for Manufacturers of class I medical devices\u201d aims to provide Manufacturers of Class I devices (other than custom-made devices) with provisions, by covering the necessary steps for placing their products on the EU market on their own name or trademark. Also, this guidance notes applies to Importers, Distributors or Third Parties who will undertake the obligations referred to in article 16 (1) of MDR. Indeed, before proceeding to the commercialization in the countries, Manufacturers must provide EC mark in accordance with Annex V and draw up the Declaration of Conformity pursuant Annex IV, but not prior to have demonstrated the conformity to MDR and to general security and performance requirements referred to in Annex I.<\/p>\r\n\r\n\r\n\r\n

\u201cMDCG 2019-16 Guidance on Cybersecurity\u201d provides Manufacturers with guidance on how to fulfil the relevant essential requirements of Annex I of the MDR and IVDR with regard to cybersecurity. Moreover, considering the complexity of the supply chain and the role which any economic operator plays thereby protecting the device from any cyber threat, further considerations concerning expectations from actors other than Manufacturer are provided in the document, besides references to regulations and other guidance referring to cybersecurity in the field of medical devices.<\/p>\r\n","protected":false},"excerpt":{"rendered":"

In December 2019 the European Medical Device Coordination Group (MDCG) released the Guidance notes for manufacturers of class I medical devices […]<\/p>\n","protected":false},"author":1,"featured_media":23282,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-13536","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"\nEUROPE: the MDCG Guidance for Class I and cybersecurity has been approved - Thema Med<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved - Thema Med\" \/>\n<meta property=\"og:description\" content=\"In December 2019 the European Medical Device Coordination Group (MDCG) released the Guidance notes for manufacturers of class I medical devices [...]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/\" \/>\n<meta property=\"og:site_name\" content=\"Thema Med\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-22T15:57:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-25T15:45:09+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"349\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"redazione\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"redazione\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#article\",\"isPartOf\":{\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/\"},\"author\":{\"name\":\"redazione\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/8cb6614629bd6664e6f294690d35677e\"},\"headline\":\"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved\",\"datePublished\":\"2020-01-22T15:57:08+00:00\",\"dateModified\":\"2023-01-25T15:45:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/\"},\"wordCount\":253,\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"image\":{\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/\",\"url\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/\",\"name\":\"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved - Thema Med\",\"isPartOf\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg\",\"datePublished\":\"2020-01-22T15:57:08+00:00\",\"dateModified\":\"2023-01-25T15:45:09+00:00\",\"breadcrumb\":{\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#primaryimage\",\"url\":\"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg\",\"contentUrl\":\"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg\",\"width\":620,\"height\":349},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.thema-med.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#website\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"name\":\"Thema Med\",\"description\":\"Quality and Regulatory Affairs for Medical Devices\",\"publisher\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.thema-med.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Organization\",\"Place\"],\"@id\":\"https:\/\/www.thema-med.com\/en\/#organization\",\"name\":\"Thema\",\"alternateName\":\"Thema\",\"url\":\"https:\/\/www.thema-med.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"contentUrl\":\"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png\",\"width\":2440,\"height\":2851,\"caption\":\"Thema\"},\"image\":{\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/\"],\"mainEntityOfPage\":{\"@id\":\"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/8cb6614629bd6664e6f294690d35677e\",\"name\":\"redazione\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b256f44c95829224dda80aff96bb893da058966fe2e8b7b58ece2b0d74ffa04d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b256f44c95829224dda80aff96bb893da058966fe2e8b7b58ece2b0d74ffa04d?s=96&d=mm&r=g\",\"caption\":\"redazione\"},\"sameAs\":[\"http:\/\/www.thema-med.eu\"],\"url\":\"http:\/\/www.thema-med.com\/en\/author\/emanuele\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved - Thema Med","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/","og_locale":"en_US","og_type":"article","og_title":"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved - Thema Med","og_description":"In December 2019 the European Medical Device Coordination Group (MDCG) released the Guidance notes for manufacturers of class I medical devices [...]","og_url":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/","og_site_name":"Thema Med","article_published_time":"2020-01-22T15:57:08+00:00","article_modified_time":"2023-01-25T15:45:09+00:00","og_image":[{"width":620,"height":349,"url":"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg","type":"image\/jpeg"}],"author":"redazione","twitter_card":"summary_large_image","twitter_misc":{"Written by":"redazione","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#article","isPartOf":{"@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/"},"author":{"name":"redazione","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/8cb6614629bd6664e6f294690d35677e"},"headline":"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved","datePublished":"2020-01-22T15:57:08+00:00","dateModified":"2023-01-25T15:45:09+00:00","mainEntityOfPage":{"@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/"},"wordCount":253,"publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"image":{"@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#primaryimage"},"thumbnailUrl":"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/","url":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/","name":"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved - Thema Med","isPartOf":{"@id":"https:\/\/www.thema-med.com\/en\/#website"},"primaryImageOfPage":{"@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#primaryimage"},"image":{"@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#primaryimage"},"thumbnailUrl":"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg","datePublished":"2020-01-22T15:57:08+00:00","dateModified":"2023-01-25T15:45:09+00:00","breadcrumb":{"@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#primaryimage","url":"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg","contentUrl":"http:\/\/www.thema-med.com\/wp-content\/uploads\/2020\/01\/7.jpg","width":620,"height":349},{"@type":"BreadcrumbList","@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.thema-med.com\/en\/"},{"@type":"ListItem","position":2,"name":"EUROPE: the MDCG Guidance for Class I and cybersecurity has been approved"}]},{"@type":"WebSite","@id":"https:\/\/www.thema-med.com\/en\/#website","url":"https:\/\/www.thema-med.com\/en\/","name":"Thema Med","description":"Quality and Regulatory Affairs for Medical Devices","publisher":{"@id":"https:\/\/www.thema-med.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.thema-med.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Organization","Place"],"@id":"https:\/\/www.thema-med.com\/en\/#organization","name":"Thema","alternateName":"Thema","url":"https:\/\/www.thema-med.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","contentUrl":"https:\/\/www.thema-med.com\/wp-content\/uploads\/2022\/11\/logo-Themasrl-COLOR-hires-2440.png","width":2440,"height":2851,"caption":"Thema"},"image":{"@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/thema-s-r-l-\/"],"mainEntityOfPage":{"@id":"http:\/\/www.thema-med.com\/en\/2020\/01\/22\/europe-the-mdcg-guidance-for-class-i-and-cybersecurity-has-been-approved\/"}},{"@type":"Person","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/8cb6614629bd6664e6f294690d35677e","name":"redazione","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.thema-med.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b256f44c95829224dda80aff96bb893da058966fe2e8b7b58ece2b0d74ffa04d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b256f44c95829224dda80aff96bb893da058966fe2e8b7b58ece2b0d74ffa04d?s=96&d=mm&r=g","caption":"redazione"},"sameAs":["http:\/\/www.thema-med.eu"],"url":"http:\/\/www.thema-med.com\/en\/author\/emanuele\/"}]}},"_links":{"self":[{"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/13536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/comments?post=13536"}],"version-history":[{"count":2,"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/13536\/revisions"}],"predecessor-version":[{"id":27031,"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/posts\/13536\/revisions\/27031"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/media\/23282"}],"wp:attachment":[{"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/media?parent=13536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/categories?post=13536"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.thema-med.com\/en\/wp-json\/wp\/v2\/tags?post=13536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}